Insider Trading April 16, 2026 05:32 PM

Innventure Director Sells $14,989 in Stock Under Pre-Arranged Plan

Transaction reported on Form 4; company posts revenue gains for 2025 while facing supply chain constraints

By Avery Klein INV
Innventure Director Sells $14,989 in Stock Under Pre-Arranged Plan
INV

Innventure, Inc. Director Daniel J. Hennessy reported the sale of 2,992 shares on April 14, 2026, executed under a Rule 10b5-1 trading plan adopted June 20, 2025. The shares moved at prices between $5.00 and $5.01 for aggregate proceeds of $14,989. Post-transaction, Hennessy directly holds 764,497 shares. Separately, the company disclosed a strong full-year 2025 revenue increase led by its Accelsius segment and more than $50 million in bookings for Q1 2026, even as supply chain constraints persist and the stock fell 4.87% to $3.80 at the close.

Key Points

  • Director Daniel J. Hennessy sold 2,992 shares on April 14, 2026 at $5.00 to $5.01, totaling $14,989.
  • After the sale Hennessy directly owns 764,497 shares.
  • Innventure reported strong full-year 2025 revenue driven by its Accelsius segment and secured over $50 million in Q1 2026 bookings, while facing supply chain constraints; the stock fell 4.87% to $3.80 at market close.

Innventure, Inc. (INV) disclosed an insider sale in a Form 4 filing with the Securities and Exchange Commission showing that Director Daniel J. Hennessy sold 2,992 shares of the company's common stock on April 14, 2026. The transactions occurred at prices ranging from $5.00 to $5.01 inclusive, producing total proceeds of $14,989.

Following the disposition reported on the Form 4, Hennessy retained direct ownership of 764,497 shares of Innventure common stock. The Form 4 indicates the sale was carried out pursuant to a predetermined Rule 10b5-1 trading plan that Hennessy adopted on June 20, 2025.

Alongside the insider transaction, company disclosures and recent reporting show operational momentum: Innventure recorded a marked increase in revenue for the full year 2025, a rise attributed principally to performance in its Accelsius segment. The company also announced it secured in excess of $50 million in new bookings for the first quarter of 2026, signaling a pipeline of potential future revenue.

Despite those top-line gains, Innventure continues to contend with supply chain constraints, a factor noted in company communications. Market reaction included a 4.87% decline in the stock price to $3.80 at the regular market close on the day referenced, with a modest rebound observed in aftermarket trading.

For investors seeking additional context on the insider transaction and company metrics, services such as InvestingPro provide tools including Fair Value estimates, financial health scores, and Pro Research Reports intended to distill filings and financial data into actionable analysis.


Clear summary

Director Daniel J. Hennessy sold 2,992 Innventure shares on April 14, 2026 under a Rule 10b5-1 plan, realizing $14,989. After the sale he directly holds 764,497 shares. The company reported strong 2025 revenue driven by the Accelsius unit and more than $50 million in Q1 2026 bookings, while supply chain issues persist and the stock fell 4.87% to $3.80 at close with a small aftermarket recovery.


Key points

  • Insider transaction: Daniel J. Hennessy sold 2,992 shares at $5.00 to $5.01 on April 14, 2026, for $14,989 total.
  • Post-sale holdings: Hennessy directly owns 764,497 shares of Innventure common stock.
  • Company performance: Strong revenue growth in 2025 driven by the Accelsius segment and over $50 million in new bookings for Q1 2026; supply chain constraints remain.

Risks and uncertainties

  • Supply chain constraints cited by the company may affect production and delivery schedules; this presents operational risk to revenue realization.
  • Market volatility: the stock declined 4.87% to $3.80 at market close on the referenced day, reflecting near-term price sensitivity.
  • Insider sales under a Rule 10b5-1 plan do not indicate future corporate actions; the sale was executed under a pre-arranged trading plan adopted June 20, 2025.

Risks

  • Persistent supply chain constraints could hinder Innventure's ability to convert bookings into revenue on schedule.
  • Short-term share volatility is evident after a 4.87% intraday decline to $3.80, creating market risk for equity holders.
  • The insider sale was executed under a Rule 10b5-1 plan adopted on June 20, 2025, which reflects a pre-arranged disposition rather than a spontaneous indicator of future company performance.

More from Insider Trading

Schwab Banking Chief Sells $1.57M in Stock After Option Exercise; Analysts Adjust Targets Amid Growth and Strategic Moves Apr 16, 2026 Adaptive Biotechnologies President Executes Stock Sales and Option Exercises Worth About $1.2M Apr 16, 2026 Oncology Institute Director Disposes $335K in Shares Amid Recent Stock Strength Apr 16, 2026 Dexcom Legal Chief Sells $107,168 in Stock; Holds 111,204 Shares Including 77,603 Unvested RSUs Apr 16, 2026 Major shareholder trims stake in Rocky Mountain Chocolate Factory as company rolls out omnichannel plan Apr 16, 2026